Novartis supplies NETSPOT DOTATATE to Cambridge University Hospitals
- Cambridge University Hospitals NHS Foundation Trust
- East of England
- 28 October 2025 to 27 January 2026
Novartis Pharmaceuticals UK Limited supplied NETSPOT DOTATATE to Cambridge University Hospitals NHS Foundation Trust.
NETSPOT DOTATATE is a radiopharmaceutical kit used for PET imaging of neuroendocrine tumours. The trust bought it to support its diagnostic work in the clinic.
The £10,560 contract ran for three months from October 2025 and was due to end in January 2026.
- What
- Radiopharmaceuticals and contrast media
- Value
- £10,560
- How it was bought
- Not published
- Dates and next
- Oct 2025 to Jan 2026